创模生物科技(北京)有限公司

CN / En

NEWS

Introducing the InnoModels Biotechnology In-Situ Modeling Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-15 16:20
  • Views:

(Summary description)As the field of neuroscience research continues to develop and deepen, researchers' need to simulate and analyze the complex structure and function of the brain is becoming more and more urgent. In this context, with its leading brain in-situ modeling platform technology, InnoModels Biotechnology (Beijing) Co., Ltd. has provided a new breakthrough point for neuroscience research, and revolutionized the field of disease modeling, drug testing, and individualized medicine.

Introducing the InnoModels Biotechnology In-Situ Modeling Platform

(Summary description)As the field of neuroscience research continues to develop and deepen, researchers' need to simulate and analyze the complex structure and function of the brain is becoming more and more urgent. In this context, with its leading brain in-situ modeling platform technology, InnoModels Biotechnology (Beijing) Co., Ltd. has provided a new breakthrough point for neuroscience research, and revolutionized the field of disease modeling, drug testing, and individualized medicine.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-15 16:20
  • Views:
Information

As the field of neuroscience research continues to develop and deepen, researchers' need to simulate and analyze the complex structure and function of the brain is becoming more and more urgent. In this context, with its leading brain in-situ modeling platform technology, InnoModels Biotechnology (Beijing) Co., Ltd. has provided a new breakthrough point for neuroscience research, and revolutionized the field of disease modeling, drug testing, and individualized medicine.
Brain in-situ modeling platform introduction:
InnoModels' in-situ brain model platform is a technology that utilizes state-of-the-art cell culture and tissue engineering methods to transplant human or animal brain tissue cells into an in vitro environment in the laboratory and maintain their in-situ structure and function. The platform not only simulates the natural growth environment of the brain, but also provides a realistic and complex research platform for neuroscience research by simulating the state of various neurological diseases.
Platform features:
1. In-situ structural restoration
InnoModels' in-situ brain model platform can accurately restore the in-situ structure of the brain tissue, including neuronal connections and distribution. This highly reproducible model enables researchers to better simulate and understand the complex functions of the brain, and then explore the pathogenesis and treatment of neurological diseases.
2. Disease Modeling
The platform can be used to model a variety of neurological diseases, such as Alzheimer's disease and Parkinson's disease. By simulating the pathological process of these diseases, researchers can study the pathogenesis and influencing factors of the diseases in depth and provide strong scientific support for the treatment and prevention of the diseases.

 


3. Drug Testing Platform
InnoModels' in situ brain modeling platform can also be used as a platform for drug testing, allowing researchers to assess the effects of new drugs on brain function and provide more accurate predictions for drug development. In addition, the platform can be combined with systemic inoculation technology to further simulate drug metabolism and immune responses in the human body, providing an important reference for the clinical application of drugs.
4. Personalized medical support
The technical characteristics of the biomimetic in situ brain model platform enable it to provide strong support for individualized medical treatment. By simulating the brain disease states of different patients, researchers can formulate more accurate treatment plans for individual differences, improving treatment effects and patients' quality of life.
Future Prospects:
With the continuous development of brain in-situ modeling technology, InnoModels will continue to drive innovation in this field. In the future, we expect to see the creation of more disease models, as well as more accurate drug testing and customized treatment plans. This technology is expected to revolutionize the field of neuroscience and thus drive neurological disease research and treatment forward.
Conclusion:
The InnoModels Biotechnology Brain In Situ Modeling Platform represents the cutting edge of neuroscience research. The application of this platform will help us understand the structure and function of the brain in a more comprehensive and in-depth way, and provide new ideas and possibilities for the treatment and prevention of neurological diseases. With the continuous development of this field, we are looking forward to the future prospects of neuroscience research.

Keyword:

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
Previous page
1
2
42
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司